Spotlight on Spironolactone Oral Suspension for the Treatment of Heart | VHRM
Reappraisal on pharmacological and mechanical treatments of heart failure | Cardiovascular Diabetology | Full Text
Hormones and Hemodynamics in Heart Failure | NEJM
Pathophysiology of high potassium concentration in heart failure. | Download Scientific Diagram
Pharmaceuticals | Free Full-Text | COVID-19—The Potential Beneficial Therapeutic Effects of Spironolactone during SARS-CoV-2 Infection | HTML
Biomolecules | Free Full-Text | Spironolactone and XPB: An Old Drug with a New Molecular Target | HTML
Diuretics Part 2
Mineralocorticoid receptor antagonists, a class beyond spironolactone — Focus on the special pharmacologic properties of eplerenone - International Journal of Cardiology
Combined aquaretic and diuretic therapy in acute heart failure | IJNRD
Association Between Mineralocorticoid Receptor Antagonist Use and Outcome in Myocardial Infarction Patients With Heart Failure | Journal of the American Heart Association
Aldosterone antagonists
Proposed Treatment Algorithm for the Use of Spironolactone in Heart... | Download Scientific Diagram
Association of Active and Passive Components of LV Diastolic Filling With Exercise Intolerance in Heart Failure With Preserved Ejection Fraction: Mechanistic Insights From Spironolactone Response | JACC: Cardiovascular Imaging
Interaction Between Spironolactone and Natriuretic Peptides in Patients With Heart Failure and Preserved Ejection Fraction: From the TOPCAT Trial - ScienceDirect
K-Sparing Diuretics - Renal - Medbullets Step 1
treatment_of_heart_failure [TUSOM | Pharmwiki]
Aldactone Mechanism of Action | MIMS Philippines
Beyond Furosemide: The Role of Diuretics in Congestive Heart Failure Part 2 - Spironolactone | Today's Veterinary Practice
Pharmacotherapy of Heart Failure | Basicmedical Key
Effects of mineralocorticoid receptor antagonist spironolactone on atrial conduction and remodeling in patients with heart failure - Journal of Cardiology
Interaction Between Spironolactone and Natriuretic Peptides in Patients With Heart Failure and Preserved Ejection Fraction: From the TOPCAT Trial - ScienceDirect
Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies - The Lancet Diabetes & Endocrinology
Spironolactone – Mechanism, side effects, interactions and precautions